Juvenile chronic arthritis (JCA) is an heterogeneous condition, which is currently divided into different subtypes according to symptoms at onset.' 2 Among numerous immunological abnormalities seen in JCA only antinuclear antibodies and IgM rheumatoid factor are currently thought to be useful in patient classification and management.2 3 Some autoantibodies with defined specificity, such as antihistone4 5 and anticollagen antibodies,6 7 14 Briefly, serum samples were diluted 1/50 in 10% fetal calf serum in phosphate buffered saline, pH (PBS-FCS), and incubated in triplicate for three hours in polyvinyl microtitre plates previously coated with 25 ml of 50 mg/ml cardiolipin in ethanol (Sigma Chemical, St Louis, Missouri, United States), washed in PBS, and blocked with PBS-FCS for one hour. After three additional washings the plates were incubated with a peroxidase conjugated rabbit antiserum selectively directed to human IgG, IgM, or IgA (Dakopatts, Denmark) at 1/1000 dilution in PBS-FCS. After three washings 100 ml of 2 mg/ml o-phenylenediamine (Sigma) in 0-1 M phosphate buffer pH 6 plus 300/o H202 was added to each well. The reaction was stopped by adding 2 M H2SO4, and the optical density was read at 492 nm with a Titertek multiscan reader (Flow Laboratories 
